Career Development Program

职业发展奖将用于支持翻译胰腺癌的职业发展 来自以下类别之一的个人的癌症研究： 1)医学肿瘤学、胃肠病学、病理学或外科学的临床研究员; 2)讲师或助理教授级别的初级教员，无论是寻求培训的临床教员 并有机会建立一个职业生涯，包括基础科学研究，或基础科学教师谁 需要额外的培训或机会进行转化研究; 3)高级博士后研究员谁是在进入学术队伍和建立点 独立研究计划; 4)已建立的临床教师谁需要在基础或转化研究的额外培训，以 建立一个翻译研究计划。 我们将支持一个新的候选人在每一年的补助金的水平150，000美元，每年最多两个 每个奖项的年数（75，000美元将由SPORE计划提供，75，000美元将由 UNMC Eppley癌症中心的配套资金）。参加这个项目的人必须承诺 实质性的努力（至少50%，以及更高百分比的努力是强烈鼓励的，并将获得 优先选择）到SPORE相关的翻译研究。资金可以用于支付工资或任何其他 发展方面（研究费用），被认为是必要的候选人成功， 建立转化性胰腺癌研究项目。第一年后审查进展情况 并决定继续支持或将候选人的努力转向另一个领域， 如果没有足够的研究进展。候选人必须提交NIH G或R系列补助金 在该奖项的第二年申请，主要集中在胰腺癌研究。

Career Development Awards will be used to support the development of careers in translational pancreatic cancer research by individuals from one of the following categories: 1) clinical fellows in medical oncology, gastroenterology, pathology, or surgery; 2) junior faculty members at the instructor or assistant professor level, either clinical faculty who seek training and an opportunity to establish a career that includes basic science research, or basic science faculty who want additional training or an opportunity to undertake translational research; 3) senior postdoctoral fellows who are at the point of entering the academic ranks and establishing independent research programs; 4) established clinical faculty who require additional training in basic or translational research in order to establish a translational research program. We will support one new candidate in each year of the grant at a level of $150,000 per year for up to two years for each award ($75,000 will be provided by the SPORE program and $75000 will be provided in matching funds by the UNMC Eppley Cancer Center). Individuals in this program are required to commit substantial effort (a minimum of 50%, and higher percent efforts are strongly encouraged and will receive preferential selection) to SPORE related translational research. Funds can be used for salaries or any other aspect of development (research costs) that are deemed necessary for the candidate to succeed in establishing a translational pancreatic cancer research program. Progress is reviewed after the first year and there is a decision to continue support or redirect the efforts of the candidate into another area of research if there is insufficient progress. The candidate is required to submit an NIH G or R series grant application during the second year of the award, that is primarily focused on pancreatic cancer research.